My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

4.710 -0.770 (-14.05%)

Official Closing Price Updated: 8:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Earnings Preview: NovaBay Pharmaceuticals ↗

March 29, 2023

Via Benzinga

NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023

March 23, 2023

From NovaBay Pharmaceuticals, Inc:

Via Business Wire

Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel

March 14, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health

March 07, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7

February 06, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

January 31, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market

January 17, 2023

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 14, 2022

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China

November 29, 2022

From NovaBay® Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm

November 17, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 14, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 16, 2022

On Wednesday, 70 companies set new 52-week lows.

Via Benzinga

NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split

November 14, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14

November 09, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum

October 26, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV

October 19, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season

October 18, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket ↗

October 10, 2022

Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 10, 2022

We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them!

Via InvestorPlace

NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale

October 10, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price

October 07, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

September 23, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

September 22, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket ↗

September 16, 2022

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.

Via Benzinga

NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum

September 13, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance

September 12, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.